Beauty Tips Online

Archive for June, 2014

Benign prostatic hyperplasia: Benign prostatic hyperplasia (BPH) is a conunon condition in the aging male and is associated with a range of sexual dysfunctions.

In one study, over 44% of men with severe LUTS complained of unsuccessful coitus, compared with only 13% of those with milder symptoms. However, a direct causal relationship between BPH, LUTS and ED seems unlikely. Loss of sexual drive, orgasmic and ejacidatory problems have been reported in untreated BPH, as well as ED. Treatments for BPH are also associated with ED and sexual dysfunction. Ejaculatory problems are the most common, with both medical and surgical treatment . According to one meta’ analysis, the incidence of ED following transurethral resection of the prostate (TURP) is between 3% and 32%. However, a more recent prospective study suggested that TURP does not cause ED.

Psychological factors, including the man’s response to ejaculatory dysfunction, may play an important part . There is evidence that the 5 alpha-reductase inhibitor finasteride results in a reduction in libido in roughly 5% of BPH patients and a reduction in erectile functioning. In general, alpha’blockers have little effect on sexual function, although tamsulosin has been shown to produce retrograde ejaculation in up to 15% of BPH patients. Most men with BPH, or on BPH treatment , can be safely and effectively treated for ED – cheap viagra Australia.

Prostate cancer: It is very unusual for ED to be the first symptom of prostate cancer, although many men wit h ED are very concerned that it might be in their case. It is often treatments for prostate cancer that lead to sexual dysfunction, rather than the disease itself. Medical treatments to suppress androgen action, such as GnRH agonists (goserelin, leuprorelin) or androgen receptor blockers (cyproterone acetate, flutamide, bicalutamide), frequently cause a marked loss of sexual interest and ED. This effect is most pronounced with GnRH analogs and can last for many months after treatment is vsithdrawn; it seems to be less of a problem with the androgen receptor blocker bicalutamide. Even so, around 50% of men taking bicalutamide 50 mg daily will have ED. ED is a common problem following radical prostatectomy. Studies have reported ED rates of 30—100% following such surgery